Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Harvard Business School
AstraZeneca
Medtronic
Mallinckrodt

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Ornidazole


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Ornidazole?

Ornidazole is an investigational drug.

There have been 7 clinical trials for Ornidazole. The most recent clinical trial was a Phase 2 trial, which was initiated on March 3rd 2018.

The most common disease conditions in clinical trials are Recurrence, Crohn Disease, and Infection. The leading clinical trial sponsors are Assistance Publique - Hôpitaux de Paris, Juan Blanco Carrión, and University of North Carolina, Chapel Hill.

There are four hundred and twenty-five US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Ornidazole
TitleSponsorPhase
Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer SurgeryAssistance Publique - Hôpitaux de ParisPhase 3
Mechanical Bowel Preparation and Oral Antibiotics Before Rectal Cancer SurgeryAssistance Publique - Hôpitaux de ParisPhase 3
Metronidazole as an Adjunct of Non- Surgical Treatment of Peri-implantitisOsteology FoundationPhase 4

See all Ornidazole clinical trials

Clinical Trial Summary for Ornidazole

Top disease conditions for Ornidazole
Top clinical trial sponsors for Ornidazole

See all Ornidazole clinical trials

US Patents for Ornidazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ornidazole   Start Trial Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof The Regents of the University of California (Oakland, CA)   Start Trial
Ornidazole   Start Trial Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)   Start Trial
Ornidazole   Start Trial Drug device configured for wireless communication Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ)   Start Trial
Ornidazole   Start Trial Treatments for gastrointestinal conditions Board of Regents, The University of Texas System (Austin, TX) St. Jude Children's Research Hospital, Inc. (Memphis, TN)   Start Trial
Ornidazole   Start Trial Boron-containing small molecules as antiprotozoal1 agents MMV MEDICINES FOR MALARIA VENTURE (Geneva, CH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ornidazole

Drugname Country Document Number Estimated Expiration Related US Patent
Ornidazole European Patent Office 2981556 2033-04-02   Start Trial
Ornidazole World Intellectual Property Organization (WIPO) 2014165513 2033-04-02   Start Trial
Ornidazole World Intellectual Property Organization (WIPO) 2014052836 2032-09-27   Start Trial
Ornidazole European Patent Office 3151906 2034-06-03   Start Trial
Ornidazole World Intellectual Property Organization (WIPO) 2015187289 2034-06-03   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Medtronic
Express Scripts
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.